• Breaking the Nuclear Barrier: How DNA–Peptide Conjugates Are Advancing Non-Viral Gene Delivery

    Abstract Non-viral gene delivery has emerged as a promising alternative to viral vectors, offering advantages in safety, scalability, and payload flexibility. Yet despite major progress in lipid nanoparticles and synthetic carriers, one fundamental biological hurdle continues to limit its effectiveness: DNA must reach the nucleus to be expressed. A recent Nature Communications study introduces a […]

  • From Thymus to Immunomodulation: Linking Physicochemical Profiles to the Biological Activity of Bovine Thymic Peptides

    Abstract Thymic peptides are recognized for their central role in immune regulation, yet many thymus-derived preparations remain insufficiently characterized despite long-standing therapeutic and nutraceutical use. This blog examines a recent comparative study evaluating two experimental bovine thymic peptide preparations alongside the clinically authorized reference Thymus Factor X® (TFX). By integrating physicochemical profiling with functional cell-based […]

  • When Binding Is Not Enough: Solving the Delivery Problem in Antisense PNA Research

    Antisense Technologies at a Crossroads: When Delivery Limits Discovery Antisense technologies have become indispensable tools in modern molecular biology and therapeutic research. Modalities such as antisense oligonucleotides (ASOs), small interfering RNA (siRNA), and peptide nucleic acids (PNAs) allow researchers to modulate gene expression with high sequence specificity. Over the past two decades, advances in target […]

  • From Innate Immunity to Therapeutic Potential: Evaluating Recombinant LL-37 Against Resistant Pathogens

    Introduction: The Persistent Gap in Antimicrobial Development The rapid escalation of antimicrobial resistance (AMR) continues to undermine the effectiveness of conventional antibiotics, particularly against pathogens belonging to the ESKAPE group. Despite decades of antibiotic discovery, the clinical pipeline for new antibacterial agents remains limited, while resistance mechanisms evolve at an accelerating pace. This imbalance has […]

  • How Permeation Enhancers Enable Oral Peptide Drugs: A Molecular View from SNAC and Semaglutide

    For decades, oral delivery of peptide drugs has been one of the most persistent challenges in pharmaceutical science. Peptides are intrinsically ill-suited for oral administration: they are rapidly degraded by proteases and exhibit extremely low passive permeability across epithelial membranes. While injectable formulations have enabled the clinical success of many peptide therapeutics, oral delivery remains […]

  • Retro-Inverted Peptides: A New Design Rule for Precision Antimycobacterial Therapy

    Abstract Tuberculosis remains a global health emergency, exacerbated by the rapid rise of drug-resistant Mycobacterium tuberculosis and the inherent limitations of conventional antibiotics. Host defense peptides offer a promising alternative due to their membrane-targeting mechanisms, but their clinical potential has been constrained by poor stability and inconsistent activity. Recent research published in Nature Communications challenges […]

  • Elamipretide: A Mitochondria-Targeted Peptide for Cardiolipin-Focused Research

    Abstract Mitochondrial dysfunction is a central pathological feature of numerous diseases, including cardiovascular disorders, neurodegeneration, metabolic syndromes, and age-related tissue decline. Elamipretide (SS-31, MTP-131) is a mitochondria-targeted tetrapeptide developed to address mitochondrial impairment through selective interaction with cardiolipin, a phospholipid essential for inner mitochondrial membrane integrity and bioenergetic function. Structurally optimized for cellular permeability and […]

  • Decoding Peptide Materials: How Sequence Context Shapes Supramolecular Assembly

    Abstract Peptide-based materials have emerged as a versatile platform for designing functional and adaptive soft matter, yet their self-assembly behavior often defies simple design rules. Traditional approaches that classify peptides by hydrophobicity, charge, or secondary-structure motifs frequently fail to predict material outcomes. Recent advances reveal that peptide assembly is governed by a context-dependent assembly code, […]

  • Peptide Cancer Vaccines Revisited: Overcoming Biological Limitations Through Rational Design

    Abstract Peptide-based cancer vaccines were once regarded as a promising yet ultimately unsuccessful immunotherapeutic strategy, largely due to limited clinical efficacy in early trials. However, these outcomes reflected fundamental biological and design limitations rather than intrinsic shortcomings of peptide antigens. Advances in cancer immunology have clarified the essential requirements for effective cytotoxic T lymphocyte (CTL) […]

  • Unlocking Bioactive Peptide Potential: How Advanced Fractionation Strategies Enhance Functionality

    Abstract Bioactive peptides derived from food proteins have gained increasing attention due to their diverse health-promoting properties and expanding applications in functional foods, nutraceuticals, cosmetics, and biomedicine. However, crude protein hydrolysates often exhibit inconsistent or diluted bioactivity because they contain complex mixtures of peptides with varying structures and functions. Fractionation has therefore emerged as a […]

No products in the cart.